Evidence map›Paper›PMID 31205495›Full record

ArticleTherapeutic advances in neurological disorders2019

Preserved caudate function in young-onset patients with Parkinson's disease: a dual-tracer PET imaging study.

Yu-Jie Yang, Jing-Jie Ge, Feng-Tao Liu, Zhen-Yang Liu, Jue Zhao, Jian-Jun Wu, Yilong Ma, Chuan-Tao Zuo, Jian Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in neurological disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. The combination ofQuantitative imaging in medicine and surgery · 2024
    Article
  3. Article
  4. EJNMMI physics · 2024
    Article
  5. Article
  6. Article
  7. Characteristics and influencing factors ofFrontiers in neurology · 2023
    Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yu-Jie YangDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Jing-Jie GePET Center, Huashan Hospital, Fudan University, Shanghai, China, and Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, China.
Feng-Tao LiuDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Zhen-Yang LiuDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Jue ZhaoDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Jian-Jun WuDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Yilong MaCenter for Neurosciences, Feinstein Institute for Medical Research, New York, USA.
Chuan-Tao ZuoDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Jing'an District, Shanghai, 200040, China; Human Phenome Institute, Fudan University, 825 Zhangheng Road, Pudong District, Shanghai, 201203, China.
Jian WangDepartment of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Jing'an District, Shanghai, 200040, China; Human Phenome Institute, Fudan University, 825 Zhangheng Road, Pudong District, Shanghai, 201203, China.ORCID https://orcid.org/0000-0001-9952-0898
Fudan University · CNFeinstein Institute for Medical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a highly heterogeneous clinical entity. Patients with young-onset PD (YOPD) show some characteristic manifestations to late-onset PD (LOPD). The current study aimed to investigate the cerebral dopaminergic and metabolic characteristics in YOPD with positron emission tomography (PET) imaging. In our study, 103 subjects (42 YOPD and 61 LOPD patients) accepted both

Indexed as

age of onsetdopamine transportermetabolic networkParkinson’s diseasepositron emission tomography

Identifiers

PMID31205495
PMCPMC6535758
OpenAlexW2945659433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.